PROVIDER PROFILE · NPI 1174537104

Matthew Peltz

Internal MedicineRedding, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

3,889

Beneficiaries

—

Total drug cost

$218K

Distinct drugs

Brand share

17.2%

Top prescribed drugs

Atorvastatin Calcium257 claims

Furosemide192 claims

Amlodipine Besylate166 claims

Levothyroxine Sodium160 claims

Potassium Chloride140 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Matthew Peltz's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
KAISER FOUNDATION HOSPITALS	187	240

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
KAISER FOUNDATION HOSPITALS	26	36

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history